BioLife Solutions, Inc. (BLFS)

23.72 +0.27 (+1.15%) At close: 04:00PM EDT

BioLife Solutions, Inc.

3303 Monte Villa Parkway
Suite 310
Bothell, WA 98021
United States
425 402 1400
https://www.biolifesolutions.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 409

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Roderick de Greef	CEO & Chairman	1.63M	N/A	1960
Mr. Troy Wichterman	Chief Financial Officer	485.2k	17.47k	1985
Ms. Karen Foster	Chief Quality & Operations Officer	395.2k	N/A	1960
Dr. Aby J. Mathew Ph.D.	Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer	448.2k	2.68M	1972
Mr. Todd Berard	Chief Marketing Officer	286.49k	N/A	1969
Ms. Sarah Aebersold J.D.	Chief Human Resources Officer	N/A	N/A	1976
Mr. Garrie Richardson B.Sc., M.B.A.	Chief Revenue Officer	N/A	N/A	1973

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Corporate governance

BioLife Solutions, Inc.’s ISS governance QualityScore as of 18 September 2024 is 7. The pillar scores are Audit: 10; Board: 8; Shareholder rights: 3; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.